Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial ...

An anonymous coder, writing to 404media under the fake name Aaron B, has also been feeling the malaise, and he's doing ...

An international team of scientists have discovered that soap could be important to helping our understanding of complex ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...

Andrew Smith, cofounder of the private-equity firm Savory Fund, joins the podcast to talk about investing in emerging ...

The overhead view is of me in a maze.” I don’t know what it says about me that the great Trey Anastasio and Tom Marshall of ...

Here’s a look at how the new Starbucks CEO is changing some of the moves made by Laxman Narasimhan and Howard Schultz as ...

January 29, 2025. More for You ...

Xiomara Mejia’s house is warm again, after a monthslong battle with her landlord and a journey through a maze of Long Island ...

Arbor breaks down what your power is telling you, what electricity costs today, and how to take control of your energy ...